SCHEMBL27741973

SCHEMBL27741973

O=C(Cl)N1CCC(c2cccc(C(F)(F)F)c2)CC1O

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ HTR2C P28335 2/20 0.50
▸ DRD2 P14416 2/20 0.49
▸ CHRM4 P08173 1/20 0.45
▸ GRM2 Q14416 3/20 0.43
▸ USP5 P45974 1/20 0.43
▸ RBP4 P02753 1/20 0.41
▸ CCR2 P41597 1/20 0.41
▸ GRIN2B Q13224 1/20 0.40
▸ NOTUM Q6P988 1/20 0.40
▸ DRD4 P21917 1/20 0.40
▸ HCRTR2 O43614 1/20 0.39
▸ CHRM2 P08172 1/20 0.39
▸ HTR1A P08908 1/20 0.39
▸ DRD3 P35462 1/20 0.39
▸ HTR2B P41595 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1761033 0.82 DRD2 (0.56) HTR2CDRD2CHRM4GRM2USP5
SCHEMBL8619066 0.77 DRD2 (0.44) HTR2CDRD2CHRM4GRM2USP5
SCHEMBL1581482 0.75 DRD2 (0.58) HTR2CDRD2CHRM4GRM2USP5
SCHEMBL4813515 0.73 CHRM4 (0.58) HTR2CDRD2CHRM4GRM2USP5
SCHEMBL22816107 0.73 HTR2C (0.66) HTR2CDRD2GRM2USP5DRD4
SCHEMBL31154443 0.72 AKR1C3 (0.62) HTR2CDRD2GRM2USP5CCR2
SCHEMBL31154407 0.72 AKR1C3 (0.62) HTR2CDRD2GRM2USP5CCR2
SCHEMBL25090261 0.72 HTR2C (0.58) HTR2CDRD2GRIN2BHTR1AHTR2B
SCHEMBL25090545 0.72 HTR2C (0.58) HTR2CDRD2GRIN2BHTR1AHTR2B
SCHEMBL25090547 0.72 HTR2C (0.58) HTR2CDRD2GRIN2BHTR1AHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101448844-B Thiazolo-pyramidine / pyridine urea derivatives as adenosine a2b receptor antagonists HOFFMANN LA ROCHE 2012-07-25 — — CN disclosed
CN-101448844-A Thiazolo-pyramidine / pyridine urea derivatives as adenosine a2b receptor antagonists HOFFMANN LA ROCHE (CH) 2009-06-03 — — CN disclosed
Send feedback